Answers are grounded in this paper and cite their sources.
HBV vaccination is recommend for hemodialysis patients, but only 50-60% of the patients show seroconversion. HBV vaccine-induced generation of HBV reactive T and B cells could be detected regardless of their capacity to mount a serological response, indicating that patients without seroconversion are potentially protected by their HBV-reactive T cell pool.
No takes yet. Share an insight, caveat, or question.
Roch et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: